MedElevator Войти в исследования
← Поиск публикаций

DOI 10.64898/2025.12.09.693329

Медицинская библиотека · bioRxiv : the preprint server for biology · 2025

Mapping the circulating proteome across neurodegeneration: A harmonized, consortium-scale framework for uncovering molecular pathophysiology.

Finney Caitlin A, An Lijun, Winchester Laura M, Vogel Jacob, Wilkins Heather M, Burns Jeffrey M, Swerdlow Russell H, Slawson Chad, Rothstein Jeffrey D, Global Neurodegeneration Proteomics Consortium (GNPC), Lutz Michael W, Saloner Rowan, Shvetcov Artur

СтатьяПрепринтПеревод пока не подготовлен

Аннотация

Large-scale plasma proteomics offers unprecedented opportunities to investigate the systemic biology of neurodegeneration, yet technical heterogeneity, site-specific artifacts, and clinical confounding remain major barriers to reproducible discovery. Leveraging data from 13,733 individuals with Alzheimer's disease (AD), Parkinson's disease (PD), frontotemporal dementia (FTD), Parkinson's disease dementia (PDD), amyotrophic lateral sclerosis (ALS), and non-impaired controls in the Global Neurodegeneration Proteomics Consortium (GNPC), we present a scalable and generalizable analytical framework for harmonizing and interpreting consortium-scale proteomic datasets. Using a high-dimensional perturbation framework, we systematically benchmark five commonly used batch correction methods across a range of realistic confounding structures, including site-disease imbalance, nonlinear effects, and heteroskedasticity. Empirical Bayes modelling via limma consistently emerged as the most robust method, optimally balancing removal of site-related technical variance with retention of disease-relevant biological signal. On this harmonized foundation, we resolve neurodegenerative disease plasma signatures, including a shared immune-metabolic axis in AD and PD, neuromuscular disruption in ALS, and proteostatic imbalance in PD. Tissue and cell-type enrichment highlight widespread immune-endocrine involvement in AD and hematopoietic activation in PD. Demographically matched analyses nominate distinct, candidate biomarkers across diseases, including lipid, redox, and complement factors in AD, lysosomal and cytoskeletal proteins in PD, and muscle-derived markers in ALS. This study establishes a scalable analytical framework for integrating real-world proteomic data and provides a disease-resolved catalogue of circulating signatures to inform biomarker development and targeted intervention across neurodegenerative diseases.

Для цитирования: Finney Caitlin A, An Lijun, Winchester Laura M, Vogel Jacob, Wilkins Heather M, Burns Jeffrey M, Swerdlow Russell H, Slawson Chad, Rothstein Jeffrey D, Global Neurodegeneration Proteomics Consortium (GNPC), Lutz Michael W, Saloner Rowan, Shvetcov Artur. Mapping the circulating proteome across neurodegeneration: A harmonized, consortium-scale framework for uncovering molecular pathophysiology.. bioRxiv : the preprint server for biology. 2025. DOI: 10.64898/2025.12.09.693329.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.